KLK3 and prostate cancer: While certain limitations impact the levels and our ability to differentiate between aggressive and non-aggressive cancer types, the spotlight remains on the widely utilized prostate-specific antigen (PSA), which plays a significant role in managing prostate cancer; it is detected and quantified using Liquid Chromatography-Tandem Mass Spectrometry (LM-Tandem MS) [35].